Please provide your email address to receive an email when new articles are posted on . The Hadassah Self-Visual Acuity Screener demonstrated high reliability, accuracy and alignment with standard ...

Please provide your email address to receive an email when new articles are posted on . Mitch Ibach, OD, of Vance Thompson Vision, and colleagues conducted a phase 2, multicenter, randomized, ...

The Companies plan to file an application with the FDA in the second half of 2025. Topline data were announced from a phase 3 trial evaluating MR-141 (phentolamine ophthalmic solution 0.75%) for the ...

Up to 19% of prevalent dementia cases may be attributable to impaired vision, a cross-sectional analysis suggested. Contrast sensitivity impairment showed the strongest relationship, followed by near ...

Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuity Safety profile consistent with previous clinical trials and no treatment-related ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...

New research examined the effects of cataract surgery on visual acuity and disease activity in patients with nAMD receiving anti-VEGF treatment. The treatment intensity for underlying nAMD remained ...

enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...